Medication organizers (pill minders) increase the risk for unintentional pediatric ingestions

George Sam Wang1, Jason A Hoppe2, Lina Brou1

  • 1a Department of Pediatrics , University of Colorado Anschutz Medical Campus , Aurora , CO , USA.

Insights

Medication organizers may increase the risk of unintentional pediatric pharmaceutical ingestions. This study found a significant association between organizer use and emergency department visits for ingestion, even after accounting for other factors.

Area of Science:

  • Pediatric Emergency Medicine
  • Public Health
  • Toxicology

Background:

  • Medication organizers aim to improve adherence but may pose risks.
  • Unintentional pediatric pharmaceutical ingestions are a significant concern.

Purpose of the Study:

  • To assess the association between medication organizer use and pediatric emergency department visits for unintentional pharmaceutical ingestions.

Main Methods:

  • Cross-sectional case-control study at a children's hospital emergency department.
  • Cases: children <6 years with unintentional pharmaceutical ingestion.
  • Controls: children <6 years with non-injury complaints, matched by age and sex.

Main Results:

  • Medication organizer use was associated with a 1.8-fold increased risk of unintentional pediatric pharmaceutical ingestion.
  • In 63% of cases with organizers, children accessed the exposure medication from the organizer.
  • Caregiver knowledge of poison control centers (PCC) was low (36% unaware).

Conclusions:

  • Medication organizers may be a risk factor for pediatric pharmaceutical ingestions.
  • Further research is needed to refine prevention strategies for medication safety.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
411
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
86
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340